CLINICAL_TRIALS
trial_result
· 2011-08-11
Clinical Trial Update: Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy. [Phase 2]
Summary
Phase 2 trial evaluating lapatinib with or without trastuzumab added to standard neoadjuvant therapy for breast cancer; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 2 | Status: COMPLETED | Results posted: 2011-08-11